Company: KEQU
Filing Date: 2025-12-12
Form Type: 10-Q
Source: 0000055529-25-000054
Chunk: 12

Company: KEWAUNEE SCIENTIFIC CORP /DE/
Filing Date: 2025-12-12
Form: 10-Q
Item: Part I, Item 1
Chunk 12
---
 Current Liabilities45,810 53,712 Long-term portion of financing liability26,205 26,632 Long-term portion of seller notes22,681 23,537 Long-term portion of term loan8,960 10,412 Long-term portion of financing lease liabilities318 149 Long-term portion of operating lease liabilities7,274 8,797 Accrued pension and deferred compensation costs4,544 3,708 Deferred income taxes1,217 1,098 Other non-current liabilities349 364 Total Liabilities117,358 128,409 Commitments and ContingenciesStockholders' Equity:Common stock, $2.50 par value, Authorized – 5,000 shares; Issued – 2,969 shares; 2,941 shares; – Outstanding – 2,866 shares; 2,839 shares, on each respective date7,423 7,353 Additional paid-in-capital5,996 5,635 Retained earnings64,457 58,919 Accumulated other comprehensive loss(4,377)(3,803)Common stock in treasury, at cost, 103 shares; 103 shares, on each respective date(3,647)(3,647)Total Kewaunee Scientific Corporation Stockholders' Equity69,852 64,457 Non-controlling interest1,865 1,788 Total Stockholders' Equity71,717 66,245 Total Liabilities and Stockholders' Equity$189,075 $194,654 

See accompanying notes to Condensed Consolidated Financial Statements.

4

Kewaunee Scientific Corporation

Condensed Consolidated Statements of Cash Flows

(Unaudited)

($ in thousands)

 Six Months EndedOctober 31, 20252024Cash flows from operating activities:Net earnings$5,697 $5,253 Adjustments to reconcile net earnings to net cash provided by operating activities:Depreciation and amortization3,129 1,621 Provision for credit losses(31)23 Stock-based compensation expense1,082 691 Deferred income taxes283 (1,079)Accrued payment in kind ("PIK") interest(935)— Amortization of deferred financing costs188 — Change in assets and liabilities:Receivables3,398 3,156 Inventories(2,650)2